Alicia Madden is an infectious disease epidemiologist at Harvard Medical School working with Dr. Megan Murray. She recently completed her Master of Science in Epidemiology at the Harvard T.H. Chan School of Public Health and is currently involved in projects on tuberculosis disease severity and transmission, fungal infections, wastewater monitoring, and emerging zoonoses.
This is the largest suspected TB cohort to be evaluated with anti-Aspergillus serology. Our preliminary findings indicate that among those who are microbiologically negative for TB at the time of diagnosis, 6% or more may have CPA instead. CPA is an underrecognized differential diagnosis for TB and Aspergillus positivity may be predictive of poor response to TB treatment.
Source: Conference 2024